BARINTHUS BIOTHERAPEUTICS PLC Shareholders' Equity
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) had Shareholders' Equity of $57.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $57.07M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $66.40M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $74.21M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $84.47M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $57.07M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $66.40M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $74.21M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $84.47M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $102.38M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $115.49M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $130.03M 10-K · filed 2026-03-13 |
| 2024-09-30 | $159.29M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $156.62M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $171.83M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $186.78M 10-K · filed 2025-03-20 |
| 2023-09-30 | $195.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $217.21M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $233.30M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $242.90M 10-K · filed 2024-03-20 |
| 2022-09-30 | $243.84M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $254.40M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $252.13M 10-K · filed 2023-03-24 |